ImmuCell Corp (ICCC)
5.235
+0.12
(+2.45%)
USD |
NASDAQ |
May 08, 16:00
5.25
+0.02
(+0.29%)
After-Hours: 20:00
ImmuCell Market Cap: 40.58M for May 8, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 07, 2024 | 39.61M |
| May 06, 2024 | 39.45M |
| May 03, 2024 | 38.99M |
| May 02, 2024 | 38.75M |
| May 01, 2024 | 38.75M |
| April 30, 2024 | 38.06M |
| April 29, 2024 | 39.53M |
| April 26, 2024 | 39.84M |
| April 25, 2024 | 39.53M |
| April 24, 2024 | 39.06M |
| April 23, 2024 | 38.99M |
| April 22, 2024 | 38.99M |
| April 19, 2024 | 38.91M |
| April 18, 2024 | 39.14M |
| April 17, 2024 | 39.14M |
| April 16, 2024 | 39.14M |
| April 15, 2024 | 39.30M |
| April 12, 2024 | 38.91M |
| April 11, 2024 | 39.76M |
| April 10, 2024 | 40.30M |
| April 09, 2024 | 40.46M |
| April 08, 2024 | 41.23M |
| April 05, 2024 | 40.07M |
| April 04, 2024 | 40.07M |
| April 03, 2024 | 40.27M |
| Date | Value |
|---|---|
| April 02, 2024 | 40.61M |
| April 01, 2024 | 40.38M |
| March 28, 2024 | 41.08M |
| March 27, 2024 | 41.00M |
| March 26, 2024 | 39.99M |
| March 25, 2024 | 40.69M |
| March 22, 2024 | 40.54M |
| March 21, 2024 | 39.45M |
| March 20, 2024 | 39.45M |
| March 19, 2024 | 38.44M |
| March 18, 2024 | 38.68M |
| March 15, 2024 | 40.69M |
| March 14, 2024 | 39.92M |
| March 13, 2024 | 39.61M |
| March 12, 2024 | 39.53M |
| March 11, 2024 | 40.50M |
| March 08, 2024 | 40.30M |
| March 07, 2024 | 40.30M |
| March 06, 2024 | 40.69M |
| March 05, 2024 | 41.08M |
| March 04, 2024 | 42.32M |
| March 01, 2024 | 40.92M |
| February 29, 2024 | 40.92M |
| February 28, 2024 | 40.46M |
| February 27, 2024 | 39.84M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
27.34M
Minimum
Mar 31 2020
85.76M
Maximum
Feb 19 2021
50.82M
Average
43.62M
Median
Jun 26 2023
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.637M |
| Palatin Technologies Inc | 33.40M |
| iBio Inc | 6.655M |
| Theriva Biologics Inc | 7.116M |
| Oragenics Inc | 5.466M |
Market Cap Related Metrics
| PS Ratio | 2.321 |
| PEG Ratio | -0.0492 |
| Price to Book Value | 1.623 |
| Price | 5.235 |
| Earnings Yield | -14.33% |
| PEGY Ratio | -0.0492 |